Skin Deep

Your skin is not just a barrier. It is a sensory organ, an immune organ, a neurochemical factory — and it has its own fully functional endocannabinoid system. Which means the same regulatory language that governs your brain also governs your complexion.

What the Skin Actually Does

The skin is the body's largest organ, comprising roughly 15% of total body weight and covering approximately two square meters of surface area in an adult. Skin cells produce serotonin, beta-endorphins, and endocannabinoids. They express receptors for cortisol, adrenaline, and sex hormones. The skin has its own neuroendocrine system, producing and responding to regulatory molecules in ways that influence both local tissue health and systemic physiology. When the skin is healthy, it contributes to hormonal balance, immune function, and neurochemical regulation. When it is inflamed or dysfunctional, the effects extend far beyond the surface.

The Skin's Own ECS

CB1 and CB2 receptors are expressed throughout the skin — in keratinocytes (the primary cells of the epidermis), in sebaceous glands, in hair follicles, in sensory nerve fibers, and in mast cells and other immune cells resident in the dermis. Endocannabinoids are synthesized and degraded locally within skin tissue. The skin's ECS governs sebum production (CB2 activation in sebaceous glands regulates lipid production and the inflammatory environment of the follicle), keratinocyte proliferation and differentiation (the process that produces new skin cells and maintains the barrier), inflammatory response in the dermis (CB2 activation in dermal immune cells regulates how aggressively the skin responds to injury or pathogen exposure), and pain and itch signaling in cutaneous sensory nerves (CB1 activation modulates the sensitivity of the C-fibers that transmit itch and pain signals from skin to central nervous system).

Eczema, Psoriasis, and Acne: ECS Regulatory Failures

Three of the most common chronic skin conditions are now understood through an ECS regulatory lens. Eczema involves a compromised skin barrier — degraded tight junctions between keratinocytes — combined with a dysregulated immune response to environmental triggers. CB1 and CB2 signaling both play roles in maintaining barrier integrity and calibrating the immune response. Psoriasis involves dysregulated keratinocyte proliferation — skin cells dividing too rapidly and not differentiating correctly. ECS signaling, particularly through CB1 in keratinocytes, is directly involved in regulating this cycle. Acne involves dysregulated sebum production in sebaceous glands combined with inflammatory response to Cutibacterium acnes. CB2 signaling in sebaceous glands plays a direct regulatory role in both sebum quality and the inflammatory environment of the follicle. In all three cases, the skin's ECS is not regulating the way a well-supported system should.

What Substrate Restoration Does for the Skin

The ECS Food Protocol addresses skin health through both systemic and local mechanisms. EPA and DHA from cold-water fish are directly incorporated into keratinocyte membranes, improving their structural integrity and reducing the inflammatory baseline that drives conditions like eczema and psoriasis. Seed oil elimination removes the primary driver of systemic and cutaneous inflammation. Microbiome restoration through Priority 3 reduces the LPS-driven systemic inflammation that directly stresses the skin's barrier function. The polyphenol layer — particularly beta-caryophyllene and quercetin — provides dietary CB2 support that amplifies the skin's own regulatory signaling. The timeline is 90–120 days of consistent dietary change — the time required for keratinocyte membrane composition to meaningfully shift.

Once that substrate is in place, the skin's own ECS goes back to doing the regulating it was already built to do: sebum production calibrates itself, keratinocytes differentiate at the rate they're supposed to, dermal immune cells stop over-firing. None of that requires a cream managing it from outside. It's the same regulatory failure resolving itself, from the same direction the problem started.